Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to bronchospasm

a spasm of the bronchi that makes exhalation difficult and noisy

References in periodicals archive ?
The bronchodilator is not indicated when a rapid response is required, such as for initial treatment of acute bronchospasm.
Respiratory and Pulmonary System - Bronchospasm Drug Pipeline Report" contains detailed information on the current drug pipeline.
Boxed Warning: Risk of Acute Bronchospasm in Patients with Chronic Lung Disease Acute bronchospasm has been observed in patients with asthma and COPD using Afrezza.
Limitations of Use: As part of the ADASUVE REMS Program to mitigate the risk of bronchospasm, ADASUVE must be administered only in an enrolled healthcare facility.
Administer ADASUVE only in an enrolled healthcare facility that has immediate access on-site to equipment and personnel trained to manage acute bronchospasm, including advanced airway management (intubation and mechanical ventilation)
All currently approved drugs for COPD are bronchodilators and are indicated for bronchospasm associated with COPD, one component of this complex disease, according to Dr.
XOPENEX HFA and other beta-agonists can produce paradoxical bronchospasm, which may be life threatening.
Free asthma, allergy and exercise-induced bronchospasm (EIB) screenings
An Evaluation of Levalbuterol HFA in the Prevention of Exercise-Induced Bronchospasm
As part of the ADASUVE development program, Alexza identified a risk of bronchospasm in certain asthma and chronic obstructive pulmonary disease (COPD) patients following dosing with ADASUVE.
COMBIVENT RESPIMAT is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
Medications (such as short acting inhaled beta-agonist) and equipment to treat severe bronchospasm must be present in the testing area.
The product is also contraindicated for patients with medical conditions that may be compromised by induced bronchospasm or repeated spirometry maneuvers.
Severe infusion reactions were identified as anaphylactic reactions, bronchospasm, fever, chills, and hypotension.